A digital medicine company that

The Future of Digital Medicine


Product Roadmap



SmartTab's oral capsule for colon targeted drug delivery. Designed specifically for targeted delivery of medication.

Successfully Completed PK Pre-clinical Animal Studies in 2019. Preparing for Human Clinical Studies to begin Q4 2020. FDA submission Q2 2021. Anticipated FDA approval/clearance Q4 2021. Commercialization of prescription drug 2022.



SmartTab's oral injection capsule for biologics and large molecules. Making injections with needles a thing of the past.

Preparing PK Pre-clinical Animal Studies in a  significant strategic partnership with a large pharmaceutical company begins Q3 2020. Human Clinical Studies to begin Q1 2021. FDA submission Q4 2021. Anticipated FDA approval/clearance and commercialization of prescription drug 2023. 



SmartTab's multi-compartment capsule to reside in the stomach for a week with active ingredients to release each day.

Early design and prototyping complete. PK Pre-clinical Animal Studies to begin Q2 2021. Human Clinical Studies Q4 2021. FDA submission Q2 2022. Anticipated FDA approval/clearance and commercialization of prescription drug 2024. 


Meets Drug Delivery


Inductive Power

The SmartTab platform utilizes inductive power (no on-board batteries) and proprietary innovative smart polymer technology for the actuation and release system. We continue to advance the capabilities of wireless power for the future of digital medicine.


Real-time Monitoring

The SmartTab platform connects with a smartphone or smartwatch via bluetooth RF signal to monitor when the capsule has reached the desired location. Monitoring for statistical based therapy optimization. Real-time decision making and wireless drug delivery.


Targeted Medicine

We are developing superior drug delivery mechanisms. Using technology for an advanced drug delivery system that target's precise locations in the GI tract. When the triggering signal is sent, it releases immediately for better drug efficacy and better patient outcomes.


Increased Drug Compliance

One of the biggest problems with treatments today is compliance. With the SmartTab electronic system triggering the release, the physician knows whether the patient is adhering to the prescribed drug treatment regimen.


Lower Toxicity

By having a very specific targeted delivery system we can negate the negative side effects associated with the medicine and will be able to use lower dosages. Lower dosages means lower side effects and improved patient outcomes.


Internet of Medical Things (IoMT)

Integration with IoMT. Data can be sent into artificial intelligence and then optimize the treatment. The SmartTab platform will integrate with other systems as the future of digital health evolves.


A Clear Path to Commercialization

TargetTab™ an ingestible capsule for wireless, targeted drug delivery. The first application of the SmartTab Platform for Crohn's and other GI related diseases. 



Our Team


Robert Niichel
Founder & CEO
Douglas Miller, PhD
Chief Technology Officer
Dr. Douglas Miller has over 25 years of experience in the medical device field including academic research, multi-national corporate R&D, as well as playing key roles in three previous start-ups where he was involved in founding and commercialization. Doug has more than 20 years experience in active implantable devices and over 5 years in in-vitro diagnostics and pharmaceuticals. He has led engineering, R&D, manufacturing, quality, and regulatory functions at the VP and director level, taking products from inception to market. He also holds nine patents in the biomedical field. Doug is a published author with a BS in Electrical Engineering and an MS & PhD in Electrical/Biomedical Engineering.
Dr. Mark Brunvand
Chief Medical Officer & Clinical Director
Philip Bien
Senior Engineer
Sacha Heppell
Chief Marketing Officer

Who Would Have Thought Podcast Launches With Special Guest Natalie Hayden

Who Would Have Thought is a podcast about digital health innovation, what we know now and what we have yet to discover.

Podcast Transcript: Living Life Powerfully with Crohn's Disease


Startup Health Festival and J.P. Morgan Conference 2020

I turn the corner to Market Street and see the bright yellow Startup Health Festival sign. Walk in and there's 105 entrepreneurs all determined to transforming healthcare as we know it.


The News


Contact Us